Skip to main content
. 2013 Mar 18;141(8):1572–1584. doi: 10.1017/S0950268813000496

Table 3.

Description of studies and data used in empirical review

Study N Age (years) Immune status Genotype Range (days) Mean (days) Median (days)
Atmar & Estes (2008) [8]a 16 18–50 + GI.I 8–54 28·6 27
Florescu et al. (2008) [36]b 1 1·8 240 240 240
Gallimore et al. (2004) [35]c 1 Child rGII.3 156 156 156
Goller et al. (2004) [51]d 1 18 + n.r. 8 8 8
Goller et al. (2004) [25]e 9 79–94 + GII 2–20 10·7 10
Kirkwood & Streitberg (2008) [43]f 9 0–2 + (6), − (3) GII.4, GII.6 2–100 30·8 15
Lee et al. (2008) [37]b 1 0·8 GII.2 114 114 114
Leon et al. (2011) [24]a 13 18–48 + GI.1 8–35 21·3 21
Ludwig et al. (2008) [41]g 9 0–16 GII.4, GII.3 22–433 95·7 46
Murata et al. (2007) [14]h 23 0–3 + n.r. 5–47 17·3 16
Nilsson et al. (2003) [38]i 1 65 GII 670 670 670
Parashar et al. (1998) [52]j 1 Adult + GII 10 10 10
Schorn et al. (2010) [39]k 9 23–59 GII.4, GII.7 97–898 305 230
Siebenga et al. (2008) [49]l 8 0–69 GII.4, GIIb–GII.3 35–182 89·3 77
Seitz et al. (2011) [26]a 9 18–50 + GI.1 4–34 17·6 15
Simon et al. (2006) [42]m 12 0–24 n.r. 3–140 40·4 23
Tu et al. (2008) [9]e 14 63–93 + GII 8–44 25·2 25·5
Westhoff et al. (2009) [40]k 2 73 GII 90–165 127·5 127·5
C. L. Moe, unpublished (1)a 22 18–50 + GI.1 8–20 8·3 7
C. L. Moe, unpublished (2)a 9 18–50 + GII.2 3–20 6·9 5

+, Immunocompetent; –, immunocompromised; n.r., not reported; r, recombinant.

a Challenge study. b Case study of infant transplant recipient. c Case study of child with genetic disorder.

d Investigation of healthcare worker. e Outbreak investigation in an elderly care facility. f Prospective hospital study. g Retrospective study of paediatric oncology patients. h Outpatients at a paediatric clinic. i Case study. j Outbreak investigation of food handlers. k Study of transplant recipients. l 2-year hospital survey. m Outbreak investigation in paediatric oncology and haematology unit.